Cannabinoids

Cannabinoids Explained: THC, CBD, CBG, CBN & More | PatientsCann UK Skip to the cannabinoid library PatientsCann UK  ·  Education Understanding Cannabinoids Cannabinoids are the active compounds in cannabis. They are the reason a cannabis medicine can ease pain, calm the mind, or help with sleep. This guide explains what they are, how they work in your body, and why heating the plant changes everything. 13 cannabinoids Interactive receptor map Accurate chemical structures Plus THC metabolism On this page What are cannabinoids? How they work Raw vs heated In your body THC vs CBD The family Questions References What are cannabinoids? Cannabinoids are a family of natural compounds made by the cannabis plant. Scientists have found more than 100 of them. They are the part of the plant that makes it useful as a medicine. Each cannabinoid has its own job. THC eases pain and sickness but also causes the “high”. CBD is calming and does not make you high. Others, like CBG and CBN, are being studied for focus, sleep and much more. Your body already makes its own cannabinoid-like chemicals. Plant cannabinoids work by borrowing the same network in your body. Scientists call it the endocannabinoid system, or ECS for short. Cannabinoids rarely work alone Alongside the aroma compounds called terpenes, cannabinoids seem to work better together than apart. Scientists call this the “entourage effect”. It is one reason a whole-plant medicine can feel different from a single pure cannabinoid. Learn more on our terpenes guide. Interactive How Cannabinoids Work in the Body Your endocannabinoid system has two main “locks”, called receptors: CB1 and CB2. Cannabinoids are the “keys”. CB1 sits mostly in the brain and nerves. CB2 sits mostly in the immune system and around the body. Pick a cannabinoid below to see which locks it fits, and what that might mean for you. None Weak / indirect Partial Strong Dampens / blocks Interactive Raw vs Heated: Why Cannabis Must Be Warmed Here is something that surprises most people: raw cannabis will not get you high. The plant does not make THC or CBD directly. It makes their acid forms first, called THCA and CBDA. Only when you add heat, by vaping, smoking or cooking, do these acids lose a tiny piece (a carbon dioxide molecule) and turn into THC and CBD. This is called decarboxylation. Follow the pathway, tap any molecule to see its structure, then press Apply heat. Apply heat The plant makes acids (left). Heat turns them into the cannabinoids you know (right). Mother acid (CBGA) Acid form (raw) Neutral form (after heat) Interactive In Your Body: What Happens to THC Heating the plant makes THC, but the story does not end there. Once THC is inside you, your liver changes it step by step into new molecules. One of them is stronger than THC itself. This is the hidden reason an eaten edible can feel so different from a vape, and why the same dose can affect two people in completely different ways. The key player 11-Hydroxy-THC is a metabolite: a new molecule your body makes while breaking THC down. It is not in the plant. It fits the CB1 receptor even better than THC, so it is stronger and reaches the brain more easily. Does the route change things? Try it Inhaled (vape or smoke) Eaten (edible) Inhaled: mostly THC reaches your brainRough share of active cannabinoid in your blood THC11-OH Delta-9-THC11-Hydroxy-THC (stronger) Fast and lighter. Inhaled THC goes almost straight to your brain, mostly unchanged. Very little becomes 11-hydroxy-THC. Onset is quick (minutes) and the effect fades sooner. The breakdown pathway Full profiles:11-Hydroxy-THC THC-COOH Why edibles feel stronger When you eat cannabis, most of the THC is turned into 11-hydroxy-THC before it reaches your bloodstream. A gentle vape and an intense edible can come from the very same flower. (Huestis, 2007) Why they fail for some Everyone’s liver runs at a different speed. The main enzyme, CYP2C9, comes in different genetic versions, so blood levels from the same dose vary widely between people. (Sachse-Seeboth et al., 2009) A fast liver can rush THC through to the inactive THC-COOH and clear it before much is felt, so a normal edible seems to do nothing. Where nano-emulsions help Nano-emulsified edibles wrap THC in tiny food-safe droplets, so more is absorbed, faster, and some slips past the liver’s first pass. They do not make THC more powerful; they make the dose more reliable. (Hermush et al., 2025) Patients first: because bodies differ so much, never chase an edible with a second dose too soon; give it up to two hours. Ask your prescriber which format and strength suit you best. At a glance THC vs CBD: The Two You Hear About Most THC and CBD come from the same plant and look almost identical under a microscope, yet they behave very differently in the body. Here is the simple version. THC Delta-9-tetrahydrocannabinol Makes you high? Yes. It switches on CB1 in the brain. Mainly used for Pain, muscle spasm, nausea, appetite and sleep. How it works Directly activates the CB1 and CB2 receptors. UK status Prescription only, from a specialist doctor. Watch for Anxiety, a racing heart or dizziness at higher doses. CBD Cannabidiol Makes you high? No. It barely touches CB1. Mainly used for Anxiety, epilepsy, inflammation and calm. How it works Acts mostly on other targets, and softens THC. UK status Low-THC CBD sold as a supplement; medical CBD is prescribed. Watch for Usually well tolerated; can interact with some medicines. Full library The Cannabinoid Family Select any card to open the full profile, with its accurate chemical structure, how it works, what the research says, and safety notes. Use the filters to narrow the list. Filter: All Non-intoxicating Intoxicating Acidic (raw) Metabolite Sleep Pain Questions Cannabinoids: Your Questions Answered What is the difference between THC and CBD? THC is intoxicating: it switches on the CB1 receptor in the brain, which causes the “high” and also eases pain and nausea. CBD

Medical Cannabis Women’s Health

From menstrual pain to menopause, endometriosis to anxiety, a growing body of research and real patient experience is reshaping how women access and use prescribed cannabis in the UK.

UK-First Inpatient Medical Cannabis Policy

Devon Partnership NHS Trust has formally approved CD21, a Standard Operating Procedure that gives medical cannabis patients a clear, safe pathway to continue their lawful prescriptions while admitted to hospital. Here is what it means for you.

Bedrocan May 2026 Press Release

New Bedrocan® Concentrate Opens Up More Ways to Take Your Prescription – PatientsCann UK Skip to main content Industry News · Prescribing Options A trusted flower,now in a new form Bedrocan® — the world’s most prescribed pharmaceutical cannabis flower — is set to become available as a standardised extract concentrate for the first time. For patients, that could mean the same trusted medicine available in more ways than ever before. PatientsCann UK · Industry News · 19 May 2026 Jump to: What Is It? Formulations Why It Matters Timeline 20+ years of Bedrocan® pharmaceutical cannabis production trusted by doctors worldwide 70% THC concentration in the new Becanex PIEX Bedrocan® extract — preserving the full cannabinoid and terpene fingerprint 5+ preparation formats now possible from a single standardised concentrate, from capsules to inhalation 2026 Target launch date for pharmacy ordering across Europe, with Germany as the first market What Is It? The Bedrocan® flower you know — in concentrated form If you have been prescribed Bedrocan® flower, you will know it as one of the most consistent and well-studied pharmaceutical cannabis products available. Grown in EU-GMP-certified facilities in the Netherlands and Denmark by Bedrocan International, it has been the benchmark for standardised medical cannabis for more than two decades. Now, that same product is set to take a new form. Berlin-based extraction specialist Becanex GmbH has developed the Becanex PIEX Bedrocan® 70% THC Concentrate — an extract that, for the first time, brings the full cannabinoid and terpene fingerprint of the Bedrocan® flower into a standardised, pharmacist-ready concentrate. The extract is produced using Becanex’s proprietary PIEX (Plant-Identical Extraction) process, which is specifically designed to preserve what makes a particular cannabis strain therapeutically distinctive. In simpler terms: this is not a generic cannabis extract. It is Bedrocan® in a bottle — the same profile, in a versatile new format. What makes it different from other extracts? Many cannabis extracts are produced to isolate one or two cannabinoids — often just THC or CBD — and discard the rest. The PIEX method takes a different approach, retaining the full spectrum of naturally occurring cannabinoids and terpenes in proportions that match the original flower. Becanex describes this as “a fingerprint” of the source material, and that precision matters clinically: the interaction between cannabinoids and terpenes — sometimes called the entourage effect — is increasingly recognised as relevant to therapeutic outcomes. The result is a concentrate that is both highly potent (at 70% THC) and pharmacologically familiar to doctors and pharmacists who have already been prescribing Bedrocan® flower. “We have always been precise about how we grow our cannabis. Becanex is equally precise about how they extract it. That shared attention to detail is what makes this product worth putting in front of pharmacists, prescribers and patients. The concentrate now enables doctors to prescribe our main product Bedrocan® in multiple compounding formulations.” Jaap Erkelens — CEO, Bedrocan International Formulations More ways for pharmacists to prepare your medicine One of the most significant implications of this product for patients is flexibility. A standardised concentrate that sits in a pharmacy’s dispensary can be compounded into a wide range of preparation formats, tailored to what works best for each individual. The Becanex PIEX Bedrocan® concentrate is specifically designed for the following preparations: Oral solution Capsules Suppositories Topical forms Inhalation dosage Vaporisation What this means in practice for patients For patients currently prescribed Bedrocan® flower, this is particularly significant. If inhalation becomes difficult — whether due to respiratory concerns, lifestyle factors, or simply personal preference — a concentrated extract from the same strain could potentially be offered as an oral or capsule-based alternative, without switching to an entirely different product. The vaporisation option is also noteworthy: the concentrate can be vaporised directly, giving patients an additional inhalation route alongside the flower. This kind of flexibility within a single, consistent product profile is exactly the kind of development that helps both patients and prescribers make evidence-informed adjustments over time. It is important to note that any change to your prescription formulation must always be discussed with and authorised by your prescribing specialist. The availability of a new format does not mean your prescription changes automatically — it expands the options your clinician can consider for you. “Patients who have found a cannabis strain that works well for them shouldn’t have to compromise if they need it in a different form. With Bedrocan as our partner, we can now offer prescribers exactly that — building on a strain they already know and trust.” Sebastian Kamphorst — Director, Becanex GmbH Why It Matters Why standardisation matters for patients Consistency you can rely on One of the greatest frustrations for patients on prescribed cannabis is variability. A standardised extract — manufactured under GMP conditions from a named, controlled cultivar — reduces that uncertainty. You and your prescriber know what to expect. No need to start from scratch For patients and doctors who have already found that Bedrocan® works, this product preserves that relationship. Switching formulation format does not mean re-establishing which strain or cannabinoid profile is therapeutically appropriate. Pharmacist flexibility Compounding pharmacies are central to how many patients receive their prescribed cannabis. A concentrate designed specifically for compounding gives pharmacists more tools to prepare bespoke preparations that suit individual clinical needs. Germany first, Europe next Germany is the first market for the launch, which reflects its position as the most developed regulated medical cannabis market in Europe. UK patients should watch this development closely — it signals the direction of travel for product diversity across Europe. A decade in the making This collaboration is not simply a commercial arrangement — it has roots going back more than ten years. As early as 2014, the founding team behind Becanex worked with Bedrocan under a scientific licence to develop the first extracts from the Bedrocan® flower. At the time, the regulatory framework to bring such a product to market did not exist. Today, it does. Kamphorst reflects on this directly: the team is not

Prescription Direction in Medical Cannabis: Guidance for Clinicians and Patients

Prescription Direction in Medical Cannabis: Guidance for Clinicians and Patients – PatientsCann UK Skip to main content Education GMC Guidance Aligned CQC Standards Prescription Direction in Medical Cannabis:Guidance for Clinicians and Patients In the UK, most medical cannabis, legally termed cannabis-based medicinal products (CBPMs), is prescribed by specialists in the private sector. Issues around prescription direction, where patients are steered toward specific pharmacies or restricted product lists, have become critical ethical and professional considerations for the sector. PatientsCann UK · Education & Guidance · Published 23 March 2026 · ~6 min read GMC General Medical Council | Prescribing Standards Aligned with GMC guidance on cannabis-based products for medicinal use (2026) CQC Care Quality Commission Provider expectations for independent CBPM clinics Reviewed February 2026 Jump to Definition Legal Framework For Clinicians For Patients Summary References At a Glance Three principles that underpin this guidance Patient Owns the Prescription Once issued, a valid prescription belongs to the patient — not the clinic. Patients may take it to any appropriately registered pharmacy. Clinical Grounds Only Any direction toward a specific pharmacy or product must be clinically justified. Commercial or operational preferences are not sufficient grounds. Regulatory Accountability Independent CBPM clinics are regulated by the CQC. Professional conduct is subject to GMC oversight. Patients can raise concerns with either body. Definition What is “Prescription Direction”? Key Term ‘Prescription Direction’ refers to any practice in which a healthcare provider influences or obligates a patient to use a particular pharmacy or dispensing service, or restricts which products may be prescribed based on a clinic’s internal formulary rather than clinical considerations alone. For standard prescription-only medicines, and CBPMs alike, once a valid prescription is issued, the patient, not the issuing clinic or prescriber, owns the prescription and has the right to have it dispensed at any appropriate pharmacy. Professional guidance makes no provision for locking prescriptions to a particular dispensing outlet on non-clinical grounds. [1] This issue has grown in practical significance as the UK’s private medical cannabis sector has expanded. Patients, many managing chronic and complex conditions, must be able to access the most suitable products at pharmacies they can practically use and afford. Legal & Regulatory Framework Prescribing medical cannabis in the UK Who Can Prescribe GMC Specialist Register Only CBPMs (excluding those with a marketing authorisation like Sativex®) are predominantly unlicensed medicines. The law restricts their prescription to doctors on the GMC’s Specialist Register, acting within their area of competence. [3] Clinic Regulation Care Quality Commission Independent clinics prescribing CBPMs are regulated by the CQC, which requires clinical governance, prescriber competence, patient safety, informed consent, and compliance with controlled drugs legislation. [4] Pharmacy Supply Any Registered Pharmacy There is no single official UK “list” of pharmacies for CBPMs. Any pharmacy that is properly registered and complies with regulatory standards may dispense them once presented with a valid prescription. [5] Unlicensed Medicines and Clinical Responsibility Unlicensed medicines entail additional responsibilities for prescribers because they have not undergone the full range of regulatory assessments for safety, quality and efficacy. Prescribers must therefore be confident that the product is appropriate for the individual patient, and must explain to patients the unlicensed nature of the treatment as part of informed decision-making. [1][5] Shared Care Arrangements NHS England guidance confirms that while subsequent prescriptions may sometimes be made under shared care arrangements, initial prescriptions must be authorised by a specialist clinician. This reinforces the importance of maintaining robust clinical oversight throughout a patient’s CBPM treatment pathway. [2] Conflicts of Interest The CQC guidance confirms that providers must ensure prescribing decisions are clinically justified, appropriately documented, and made in the best interests of the patient, with systems in place to manage risk and avoid conflicts of interest. This includes ensuring that organisational or commercial arrangements do not compromise professional judgement or patient choice in prescribing or supply pathways. [4] For Clinicians Responsibilities for prescribing doctors Many private medical cannabis clinics operate internal formularies, lists of products they commonly prescribe based on clinician familiarity, supply arrangements, or existing protocols. There may be legitimate clinical reasons to prefer certain products (e.g. formulations with established pharmacological profiles or evidence bases). However, clinicians must never refuse to consider other products solely because they are not on an internal clinic list, without clinical reasoning. [1] Clinical judgement during prescribing must always focus on the patient’s individual needs rather than operational convenience or commercial preference. This is consistent with all prescribing guidance for individualised care. Do’s for Clinicians Respect patient choice of pharmacy — inform patients they may take their prescription to any appropriately registered pharmacy capable of dispensing CBPMs Provide balanced product information — discuss evidence, risks, benefits, and availability of relevant CBPMs to enable informed decision-making Explain formulary limits transparently — if prescribing experience is concentrated on certain products, clarify this and discuss why other products may be clinically appropriate Follow GMC prescribing standards — ensure decisions are based on clinical evidence and patient needs, not commercial relationships [1] Operate within CQC governance expectations — maintain transparency in prescribing practices and avoid commercial influence on clinical decision-making [4] Don’ts for Clinicians Do not require patients to use a particular pharmacy for non-clinical reasons Do not imply that prescriptions are “owned” by the clinic or that patients must dispense through a preferred partner Do not limit prescribing to products on an internal formulary if other products are clinically suitable and available Do not allow commercial arrangements with pharmacies or manufacturers to influence clinical prescribing choices Any practice that restricts patient choice on non-clinical grounds may undermine professional ethics and patient trust. For Patients Your rights as a CBPM patient Know Your Rights What you are entitled to You have the right to choose the pharmacy that dispenses your prescription, provided it is registered and authorised to supply controlled drugs and CBPMs [5] A prescription is your legal document, it may be taken to any suitable registered pharmacy Clinicians must explain the clinical basis for any recommended product, including risks and benefits, to support informed

THCa is it legal?

PatientsCann UK — THCa — Is It Legal? Education Cannabinoids February 2025 THCa — Is It Legal in the UK? Tetrahydrocannabinolic acid (THCa) is a non-psychoactive cannabinoid found in raw cannabis. This guide explains its biochemistry, therapeutic potential, and — critically — its legal status in the United Kingdom. PatientsCann UK·Education·6 February 2025 · Updated March 2026 What Is THCa? THCa is the acidic precursor to THC found naturally in raw cannabis plants. In its unheated form it is non-psychoactive — it does not produce a “high.” The Critical Caveat When heated (smoking, vaping, cooking), THCa undergoes decarboxylation and converts into THC — gaining psychoactive properties. This conversion is legally significant. Therapeutic Potential Emerging research suggests THCa may offer several health benefits in its raw form: Anti-inflammatory properties: may reduce inflammation relevant to arthritis and other inflammatory diseases Neuroprotective effects: may protect nerve cells, with applications in neurodegenerative disorders Antiemetic benefits: may alleviate nausea and vomiting for patients undergoing chemotherapy or with chronic gastrointestinal conditions Legal Status in the UK The ACMD has addressed THCa’s control status in its consumer CBD report. While THCa in its raw state does not produce psychoactive effects, its potential to convert to THC on heating means it sits in a legally complex position under UK law. Important: The legal status of THCa in the UK is not straightforwardly settled. Under the Misuse of Drugs Act 1971, cannabis and its cannabinoids are controlled. THCa products sold outside of a legitimate prescription pathway carry significant legal risk. PatientsCann UK recommends patients only access cannabinoids via licensed clinics and regulated prescribers. Educational Disclaimer This article is for educational purposes only. It is not legal advice. Laws change — always consult a qualified solicitor or your prescribing clinic for guidance specific to your situation. Mohammad Ismail “Ish” Wasway · Managing DirectorPatientsCann UK® · UK’s Medical Cannabis Patient Organisation · patientscann.co.uk

Science Behind Tropical Cannabis Aromas

Recently, scientists made an exciting discovery that sheds light on the chemistry behind those tantalising tropical aromas: Tropicannasulfur compounds (TCSCs).

What is Medical Cannabis

Cannabis Based Medical Products (CBMPs) or Medical Cannabis are medications derived from the cannabis plant

Water Activity: A Guide for Medical Cannabis Producers 

Introduction As the global demand for medical cannabis continues to surge, the attention to quality control measures becomes increasingly critical. One such parameter gaining prominence in the cannabis industry is water activity (aw). This blog delves into the multifaceted role of water activity, extending beyond its conventional association with edibles and food safety. Specifically, we explore its impact on microbial stability, storage stability of harvested buds and extracts, its correlation to product quality attributes, and its implications for shelf life. Additionally, we discuss its current inclusion in state regulations and emphasise the need for a holistic understanding of water activity in the cannabis industry. The Theory of Water Activity Water activity is not a novel concept but is deeply rooted in the fundamental laws of thermodynamics, as per Gibb’s free energy equation. It represents the relative chemical potential energy of water in a system, measured by the partial vapour pressure of water in a headspace at equilibrium with the sample. This comprehensive understanding helps differentiate water activity from moisture content, with water activity providing a more accurate indication of microbial, chemical, and physical stability in cannabis products. Water Activity and Microbial Safety Microbial contamination poses a significant threat to cannabis products, leading to allergic reactions, respiratory complications, or food borne illnesses. Water activity serves as a critical control point for preventing microbial contamination, dictating the ability of microorganisms to grow and reproduce. While moisture content is an extensive property related to purity, water activity is an intensive property directly influencing microbial growth limits. Establishing water activity below 0.63 aw is crucial for ensuring shelf stability, preventing the growth of pathogenic bacteria and moulds that could compromise product safety. Water Activity and Chemical Stability Water activity is not only a guardian against microbial growth but also a determinant of chemical stability in cannabis products. Processing biomass and edibles to water activities below 0.63 aw mitigates the risk of microbial spoilage but doesn’t guarantee unlimited shelf life. Chemical degradation, such as tetrahydrocannabinolic acid (THCA) loss due to decarboxylation, becomes a pertinent concern. Water activity influences reaction rates, with lower water activity correlating with minimised chemical degradation. The hygrothermal time model is a valuable tool for predicting reaction rates and establishing the ideal water activity range for maximising shelf life while minimising chemical degradation. Water Activity and Storage Stability Harvested cannabis must be adequately dried to facilitate storage and transport. Water activity below 0.63 aw is essential to prevent mould growth, particularly in dried biomass. Adequate packaging, with good moisture barrier properties, becomes imperative to preserve water activity levels during storage and transport. Water Activity and Regulations While water activity is recognised for its role in ensuring the safety and stability of cannabis products, its inclusion in state regulations varies. States like Nevada, California, Oregon, and Washington have incorporated water activity testing requirements into their regulations. Additionally, ASTM standards have been established to standardise water activity testing in the cannabis industry, emphasising its importance in maintaining product quality and safety. Conclusion In the dynamic landscape of the medical cannabis industry, water activity emerges as a versatile and indispensable parameter. Its influence extends from microbial safety to chemical stability, storage stability, and overall product quality. For medical cannabis producers eyeing the UK market, understanding and controlling water activity is not just a standard to maintain but a strategic move to ensure the longevity, safety, and efficacy of their products. As the industry continues to evolve, embracing the multifaceted significance of water activity will undoubtedly set exporters apart, fostering a reputation for excellence and reliability in the global market. References D.S. Reid, Water Activity in Foods (Blackwell Publishing and the Institute of Food Technologists, Ames, Iowa, 2007) pp. 15–28. A.J. Fontana, Water Activity in Foods (Blackwell Publishing and the Institute of Food Technologists, Ames, Iowa, 2007) pp. 155–171. M.S. Tapia, S.M. Alzamora, and J. Chirife, Water Activity in Foods (Blackwell Publishing and the Institute of Food Technologists, Ames, Iowa, 2007) pp. 239–271. L. Beuchat, J. Food Prot.46(2), 135–141 (1983). W. Scott, Adv. Food Res.7,83–127 (1957). National Cannabis Industry Association. https://thecannabisindustry.org/ncia-news-resources/state-by-state-policies/. (June 2019). H. Lueng, Water Activity: Theory and Applications to Food (Marcel Dekker, Inc., New York, New York, 1987) pp. 27–45. B.P Carter, R.M. Syamaladevi, M.T. Galloway, G.S. Campbell, and S.S. Sablani, Proceedings for the 8th Shelf Life International Meeting, U. Klinkesorn, Ed. (Bangkok, Thailand: Kasetsart University, 2017) pp. 40–45. H. Eyring, J. Chem. Phys.4, 283 (1936). The What, How, and Why of Water Activity in Cannabis. https://www.cannabissciencetech.com/view/what-how-and-why-water-activity-cannabis/ (December 2023). Water Activity And Cannabis. https://aqualab.com/en/knowledge-base/webinars/water-activity-and-cannabis/ (December 2023),

The Cannabis Plant: Nature’s Gift Unveiled

Introduction The cannabis plant, scientifically known as Cannabis sativa, has been a part of human history for millennia, revered for its versatility and medicinal properties. In this comprehensive blog, we will explore the fascinating anatomy, life cycle, pollination methods, defence mechanisms, habitats, and diverse types, shapes, and colours of the cannabis plant. Let’s embark on this journey of discovery and unravel the enigmatic world of cannabis. Anatomy of the Cannabis Plant The cannabis plant is a hardy, dioecious flowering plant, meaning it has separate male and female reproductive structures. Below is a simple table illustrating the basic anatomy of the cannabis plant: Plant Part Function Leaves Photosynthesis and transpiration Stems Support, nutrient transport, and storage Flowers (Buds) Reproductive structures containing cannabinoids Seeds Reproduction and dispersal of the species Roots Anchoring, nutrient and water absorption 1. Cola: The Cola refers to the cluster of buds at the top of the female cannabis plant. It contains high concentrations of cannabinoids, such as THC and CBD, making it a crucial component for medical cannabis production. Colas are carefully cultivated and harvested for their therapeutic properties, contributing to the medicinal benefits of the plant. 2. Sugar Leaf: Sugar Leaves are the small, sugar-coated leaves that surround the Cola and other buds. These leaves contain trichomes, which are resin-producing glands responsible for synthesising cannabinoids and terpenes. Sugar Leaves are also utilised in medical cannabis preparations due to their cannabinoid-rich content. 3. Pistil and Stigma: Pistils and Stigmas are the reproductive structures of the female cannabis plant. The Pistil consists of the Stigma, which is a hair-like structure designed to capture pollen during pollination. While cannabis growers typically remove male plants to prevent seed development, these female reproductive components play a significant role in medical cannabis production as they are rich in cannabinoids and other beneficial compounds. 4. Trichomes: Trichomes are tiny, crystal-like structures that cover the surface of cannabis plants, including the Cola and Sugar Leaves. These structures are the powerhouse of medicinal compounds, housing a majority of the cannabinoids and terpenes responsible for the therapeutic effects of medical cannabis. Trichomes are carefully preserved during harvesting to ensure maximum medicinal potency. 5. Fan Leaf: Fan Leaves are the large, fan-shaped leaves that emerge from the cannabis plant’s branches. While they contain minimal cannabinoid content, they play a crucial role in the photosynthesis process, providing the plant with the energy it needs to produce therapeutic compounds. Fan Leaves also contribute to the overall health and vigour of the medical cannabis plant. 6. Bract and Calyx: Bracts are modified leaves found at the base of each Cola, while Calyxes are small, cup-like structures that encase the cannabis seeds when pollinated. While Bracts and Calyxes have limited cannabinoid content, they are essential components for medical cannabis growers as they protect and support seed development, which is crucial for strain preservation and breeding purposes. Life Cycle of the Cannabis Plant The life cycle of the cannabis plant consists of several stages, each crucial for its survival and propagation. Let’s take a look at the key phases: Pollination Methods of the Cannabis Plant The cannabis plant has developed different strategies for pollination. The two main methods are: Defence Mechanisms of the Cannabis Plant To protect itself from predators and environmental stressors, the cannabis plant deploys various defence mechanisms. These include: Habitats of the Cannabis Plant The cannabis plant is remarkably adaptable and can thrive in diverse habitats, including: Various Types, Shapes, and Colours of Cannabis Cannabis exhibits a wide array of types, shapes, and colours, influenced by factors such as genetics, cultivation techniques, and environmental conditions. Below are some common cannabis types: Type Shape Colour Sativa Tall, slender Light green, orange, yellow Indica Short, bushy Dark green, purple Ruderalis Small and rugged Pale green Hybrids Varies depending on mix Combination of colours Conclusion The cannabis plant is a remarkable botanical wonder, with a rich history and countless applications in various fields. Understanding its anatomy, life cycle, pollination methods, defence mechanisms, habitats, and diverse characteristics can foster appreciation for this extraordinary plant. Whether it’s for medical purposes, recreational use, or industrial applications, the cannabis plant continues to intrigue and amaze humanity, reminding us of the wonders of nature. Disclaimer:This post aims to provide general information about the cannabis plant. Cultivation, possession, and use of cannabis is illegal without the correct authorisation Always abide by the laws and regulations put in place. Consult a qualified professional for personalised advice related to medical cannabis.